Clinical Trial Update: Comparison of Microfracture Treatment and CARTIPATCH® Chondrocyte Graft Treatment in Femoral Condyle Lesions [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Microfracture treatment with CARTIPATCH Chondrocyte Graft for femoral condyle chondral/osteochondral knee lesions has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chondral Defect of the Knee
• Osteochondral Defect of the Knee

Drugs mentioned

• CARTIPATCH Chondrocyte Graft (Chondrocyte graft)
• Microfracture (surgical microfracture)

Snippet

Sponsor: TBF Genie Tissulaire | Conditions: Knee Chondral, Osteochondral Defect | Phase 3 | Status: TERMINATED